menu-iconFind productsmenu-iconMy.Novozymes
01.10.21 | Industrial

Brewing case study:
Enzymes enable high FAN recipe to use low FAN malt

Find out how we helped our customer optimize their process

Case study

Challenge: Constraints in procuring high FAN malt made it impossible for an international brewer to brew its high RDF (78%) brand. The wort, composed of 40% maize grits and 60% malt, was brewed at high gravity. FAN levels and FAN quality were critical input to fermentation.  

Solution: We recommended FAN Boost™ and an adjusted malt mash regime. This enabled the brewery to process low FAN malt for its high adjunct, high RDF brand. The solution met all target brand specifications at the bright beer stage. 

Location: Africa 

 

densimeter malt

Want to explore more brewing cases?

Overcoming raw material quality variations

Challenge: A country-wide ban on barley import led to significant variation in raw material quality – which decreased production efficiency and quality of finished beer products for an international brewer.

Read more

Existing setup yields more brewing capacity and saves energy

Challenge: A regional brewer wanted to boost brewing capacity without investing in more fermenters. Could they reduce fermentation times, without compromising on beer quality?

Read more

More CapEx or more optimal process?

Challenge: An international brewer was capacity constrained in the fermentation/storage area and needed to release capacity to increase volume and meet demand.

Read more

Related articles

Stability_chocolate_squares_stack
12.03.24 | 8 minute read

Food For Your Mood

Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West in Anaheim, California. 
farming field with trackers harvesting crops
12.03.24 | 8 minute read

FMC to Distribute Novonesis’ Biosolutions for Plant Health in Canada

Novonesis announces an expanded partnership with FMC.
Healthy couple smiling
11.03.24 | 8 minute read

Novonesis probiotic strain receives health claim in Canada

Health Canada authorizes functional claims that the new probiotic strain CLEPIUS™ “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adults”.